ALPS Advisors’s LianBio American Depositary Shares LIAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-58,490
Closed -$116K 1096
2022
Q3
$116K Sell
58,490
-5,738
-9% -$13.7K ﹤0.01% 1024
2022
Q2
$139K Sell
64,228
-45,991
-42% -$156K ﹤0.01% 1014
2022
Q1
$409K Sell
110,219
-11,597
-10% -$47.9K ﹤0.01% 469
2021
Q4
$750K Buy
+121,816
New +$1.39M 0.01% 413

Other funds holding LIAN

ALPS Advisors's LIAN Position: Q4 2022 in Review

ALPS Advisors sold out of LianBio American Depositary Shares (LIAN) in Q4 2022, closing a stake of 58,490 shares — an estimated $116K sold.

ALPS Advisors first reported a position in LIAN in Q4 2021 and held it in 4 quarters. The position peaked at $750K in Q4 2021. 40 funds tracked by Wall St. Rank hold LIAN as of Q4 2022.

  • ALPS Advisors reported no remaining LianBio American Depositary Shares position as of Q4 2022 after selling out during the quarter.
  • ALPS Advisors sold 58,490 LianBio American Depositary Shares shares in Q4 2022, an estimated $116K.
  • ALPS Advisors first reported a position in LianBio American Depositary Shares in Q4 2021 and held it in 4 quarters.
  • ALPS Advisors's LianBio American Depositary Shares position peaked at $750K in Q4 2021.
  • 40 funds tracked by Wall St. Rank held LianBio American Depositary Shares as of Q4 2022.

Based on ALPS Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.